Effects of dimethyl quaternary propranolol (UM-272) on oxygen consumption and ischemic ST segment changes in the canine heart
- PMID: 1151752
Effects of dimethyl quaternary propranolol (UM-272) on oxygen consumption and ischemic ST segment changes in the canine heart
Abstract
The effect of dimethyl quarternary propranolol, UM-272, on myocardial oxygen consumption was determined experimentally in anesthetized, open-chest dogs in which the left anterior descending and circumflex coronary arteries were cannulated and perfused at a constant pressure. Coronary arterial and venous blood samples were collected and their oxygen content were measured. Myocardial oxygen consumption was calculated and expressed as milliliters per minute per 100 grams of left ventricle. Mean control myocardial oxygen consumption in five animals was 11.7 +/- 1.9. This was significantly reduced to 7.6 +/- 1.1 after UM-272, 10 mg/kg (P less than 0.5). In separate experiments, hearts were excised from anesthetized dogs and were perfused with oxygenated whole blood via the aorta. Coronary blood flow was held constant and oxygen consumption was calculated and expressed as milliliters per minute per 100 g of myocardium. Mean control oxygen consumption in five hearts was significantly reduced from 3.1 +/- 0.2 to 2.1 +/- 0.1 (P less than 0.01). In addition, the effect of UM-272 on myocardial ischemic injury produced in response to acute coronary artery ligation was assessed. The sum ST segment elevations from six epicardial recording sites was reduced from 34.8 +/- 4.9 to 11.3 +/- 2.1 mV (P less than .05). These data suggest that UM-272 would aid in ischemic heart disease by reducing both oxygen utilization and ischemic damage. These data, although suggestive, do not exclude other mechanisms as being related to the reduction in ST segment elevation, mechanisms which may not involve a reduction in myocardial oxygen consumption.
Similar articles
-
Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761).J Pharmacol Exp Ther. 1976 Nov;199(2):310-28. J Pharmacol Exp Ther. 1976. PMID: 978488
-
Protective effects of dimethyl-propranolol (UM-272) during global ischemia of isolated feline hearts.J Pharmacol Exp Ther. 1980 Mar;212(3):560-8. J Pharmacol Exp Ther. 1980. PMID: 7359356
-
Relationship between epicardial ST-segment elevation and myocardial ischemic damage after experimental coronary artery occlusion in dogs.J Clin Invest. 1976 Dec;58(6):1317-26. doi: 10.1172/JCI108587. J Clin Invest. 1976. PMID: 993347 Free PMC article.
-
Propranolol and experimental myocardial infarction: substrate effects.Postgrad Med J. 1976;52 Suppl 4:124-32. Postgrad Med J. 1976. PMID: 787952 Review.
-
Increased protection of the ischemic myocardium by decreased aortic pressure.Jpn Heart J. 1995 Nov;36(6):689-97. doi: 10.1536/ihj.36.689. Jpn Heart J. 1995. PMID: 8627975 Review.
Cited by
-
Disposition of pranolium chloride in dogs, baboons and monkeys.Eur J Drug Metab Pharmacokinet. 1981;6(3):179-87. doi: 10.1007/BF03189487. Eur J Drug Metab Pharmacokinet. 1981. PMID: 7308238
-
Low-dose propranolol for the protection of the left ventricle from ischaemic damage.Thorax. 1981 Nov;36(11):814-22. doi: 10.1136/thx.36.11.814. Thorax. 1981. PMID: 7330803 Free PMC article.